Biogened S.A. (WSE:BGD)
19.90
-0.10 (-0.50%)
At close: Aug 14, 2026
Biogened Market Cap
Biogened has a market cap or net worth of 48.88 million as of August 14, 2026. Its market cap has decreased by -19.11% in one year.
Market Cap
48.88M
Enterprise Value
70.92M
Revenue
109.49M
Ranking
n/a
PE Ratio
10.04
Stock Price
19.90
ChartMarket Cap Chart
Since August 31, 2011, Biogened's market cap has increased from 45.77M to 48.88M, an increase of 6.80%. That is a compound annual growth rate of 0.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 48.88M | -7.87% |
| Dec 30, 2025 | 53.06M | -6.09% |
| Dec 30, 2024 | 56.50M | 27.78% |
| Dec 29, 2023 | 44.21M | 41.73% |
| Dec 29, 2022 | 31.20M | 47.67% |
| Dec 30, 2021 | 21.12M | 1.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| KSG Agro | 51.11M |
| KBJ S.A. | 50.20M |
| IZOBLOK | 49.92M |
| Telestrada | 49.91M |
| MLK Foods Public Company LTD | 49.06M |
| CStore | 48.75M |
| MedApp | 48.03M |
| Milton Essex Spólka Akcyjna | 47.64M |